Indian Pharma Companies Set to Launch Generic Diabetes Medicines At 90% Lower Price
With the expiration of Boehringer Ingelheim’s patent on Empagliflozin, several Indian pharmaceutical companies are set to ...
NewsBytes2d
Suffering from diabetes? Your medicines are set to become cheaper
While Metformin continues to be the standard first-line treatment for Type-2 diabetes, newer therapies such as SGLT2 ...
EurekAlert!2d
VA merit grant to Wayne State University searches for new insights into onset of diabetes
A grant from the U.S. Department of Veterans Affairs (VA) will aid Wayne State University researchers in finding new insights into diabetes and its onset.